Listed
Stock Code: 065170
| Company Name | (주)비엘팜텍 |
| English Name | BL Pharmtech Corp. |
| Business Reg. No. | 3038113820 |
| CEO | 박영철 |
| Address | 경기도 용인시 수지구 신수로 767 134호(동천동, 분당수지유타워 지식산업센터) |
| Industry | 기타 가공식품 도매업 |
| Industry Code | 463 |
| Established | 1995-02-17 |
| Phone | 02-3401-4490 |
| Website | www.blpharmtech.com |
| Regular Employees | 8persons |
| Corp. Reg. No. | 1545110007397 |
Venture Certified
| 신기술기업(특허기술) | 2002-11-15 ~ 2004-11-14 | 021921031200590 | 2002-11-15 |
| 신기술기업(특허기술) | 2004-11-15 ~ 2006-11-14 | 041921031300086 | 2002-11-15 |
| 신기술기업(특허기술) | 2006-06-03 ~ 2008-06-02 | 61921031400102 | 2002-11-15 |
| 벤처투자유형 | 2025-05-07 ~ 2028-05-06 | 20250507010013 | 2002-11-15 |
Revenue CAGR -40.3%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 76B | 234B | 214B |
| Operating Profit | -18B | -56B | -23B |
| Net Profit | -72B | -70B | -222B |
| Total Assets | 342B | 428B | 629B |
| Total Liabilities | 112B | 114B | 252B |
| Total Equity | 229B | 313B | 377B |
Operating Loss: Op. profit -18B
Revenue down 67% YoY
3 Consecutive Years of Net Loss
Debt Ratio Surge (+12pp YoY)
▼ 66.0%
▲ 53.3%
▼ 39.6%
▼ 5.3%
▲ 23.1%
| Name | Position | Role |
|---|---|---|
| 박영철 | 대표이사 | 대표 |
| NPS Subscribers | 8persons |
| CEO | 박영철 |
| Est. Avg. Annual Salary | 3,44410K (28710K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -1persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 1995-12-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경기도 용인시 수지구 신수로",
"brno": "303811****",
"cappedWarning": false,
"companyName": "(주)비엘팜텍",
"estimatedAvgAnnualSalary": 34439052,
"estimatedAvgMonthlySalary": 2869921,
"fetchedAt": "2026-03-05T19:28:56.022Z",
"industryCode": "154903",
"industryName": "건강 보조용 액화식품 제조업",
"joinDate": "19951201",
"last12MonthsHired": 1,
"last12MonthsLeft": 1,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 2181140,
"monthlyTrend": [
{
"lostSubscribers": 1,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6706978",
"status": "1",
"styleCode": "1",
"subscriberCount": 8,
"turnoverMonths": 1
}{
"address": "경기도 용인시",
"ceo_name": "박영철",
"certificate": [
{
"cert_number": "021921031200590",
"changes": "",
"disclosure_date": "2002-11-15",
"first_cert_date": "2002-11-15",
"no": "1",
"type": "신기술기업(특허기술)",
"valid_period": "2002-11-15 ~ 2004-11-14"
},
{
"cert_number": "041921031300086",
"changes": "",
"disclosure_date": "2004-11-15",
"first_cert_date": "2002-11-15",
"no": "2",
"type": "신기술기업(특허기술)",
"valid_period": "2004-11-15 ~ 2006-11-14"
},
{
"cert_number": "61921031400102",
"changes": "",
"disclosure_date": "2006-06-03",
"first_cert_date": "2002-11-15",
"no": "3",
"type": "신기술기업(특허기술)",
"valid_period": "2006-06-03 ~ 2008-06-02"
},
{
"cert_number": "20250507010013",
"changes": "",
"disclosure_date": "2025-05-07",
"first_cert_date": "2002-11-15",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2025-05-07 ~ 2028-05-06"
}
],
"company_name": "(주)비엘팜텍",
"financials": {
"2022": {
"capital_stock": 44485280000,
"cost_of_sales": 8345284000,
"current_assets": 17698125000,
"current_liabilities": 24928043000,
"gross_profit": 13071298000,
"net_income": -22188374000,
"net_income_bs": -22640917000,
"non_current_assets": 45163683000,
"non_current_liabilities": 266414000,
"non_operating_expenses": 21223085000,
"non_operating_income": 1340691000,
"operating_profit": -2305980000,
"revenue": 21416581000,
"sga_expenses": 15377278000,
"total_assets": 62861808000,
"total_equity": 37667351000,
"total_liabilities": 25194457000
},
"2023": {
"capital_stock": 44485280000,
"cost_of_sales": 10181801000,
"current_assets": 15746859000,
"current_liabilities": 6989196000,
"gross_profit": 13196613000,
"net_income": -7038948000,
"net_income_bs": -7050756000,
"non_current_assets": 27015852000,
"non_current_liabilities": 4452767000,
"non_operating_expenses": 13247720000,
"non_operating_income": 11791443000,
"operating_profit": -5582671000,
"revenue": 23378414000,
"sga_expenses": 18779283000,
"total_assets": 42762711000,
"total_equity": 31320749000,
"total_liabilities": 11441963000
},
"2024": {
"capital_stock": 4448528000,
"cost_of_sales": 1957372000,
"current_assets": 5730949000,
"current_liabilities": 6209398000,
"gross_profit": 5662970000,
"net_income": -7182705000,
"net_income_bs": -7182705000,
"non_current_assets": 28447166000,
"non_current_liabilities": 5026706000,
"non_operating_expenses": 9827060000,
"non_operating_income": 4486798000,
"operating_profit": -1842443000,
"revenue": 7620342000,
"sga_expenses": 7505413000,
"total_assets": 34178116000,
"total_equity": 22942012000,
"total_liabilities": 11236104000
}
},
"industry": "기타 가공식품 도매업",
"investment": [
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2023-10-30"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2023-10-30"
}
],
"phone": "02-3401-****",
"source": "pg_migration"
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |